1887

Journal of Medical Microbiology logo

Volume 47, Issue 11

Infections in children Free

Proceedings of the Fourth Liverpool School of Tropical Medicine and Bayer Symposium on Microbial Disease

Preview this article:
Preview Magnify

There is no abstract available.

  • Received:
  • Accepted:
  • Published Online:
© 1998 The Pathological Society of Great Britain and Ireland
Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-47-11-943
1998-11-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/47/11/medmicro-47-11-943.html?itemId=/content/journal/jmm/10.1099/00222615-47-11-943&mimeType=html&fmt=ahah

References

  1. Davies E. G., Elliman D. A. C., Hart C. A., Nicoll A., Rudd P. T. Manual of childhood infections. London: WB Saunders; 1996
     [Google Scholar]
  2. Gangarosa E. J., Galazka A. M., Wolfe C. R. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351:356–361
     [Google Scholar]
  3. Hart C. A., Beeching N. J., Duerden B. I. (eds) Tuberculosis into the next century. J Med Microbiol 1996; 44:1–34
     [Google Scholar]
  4. Coulter J. B. S. HIV infection in African children. Ann Trop Paediatr 1993; 13:205–215
     [Google Scholar]
  5. Mertens T. E., Low-Beer D. HIV and AIDS: where is the epidemic going?. Bull World Health Organ 1996; 74:121–129
     [Google Scholar]
  6. Asiimwe-Okiror G., Opio A. A., Musinguzi J., Madraa E., Tembo G., Carael M. Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS 1997; 11:1757–1763
     [Google Scholar]
  7. Commenges D., Alioum A., Lepage P., Van de Perre P., Msellati P., Dabis F. Estimating the incubation period of paediatric AIDS in Rwanda. AIDS 1992; 6:1515–1520
     [Google Scholar]
  8. Serwadda D., Wawer M. J., Musgrave S. D., Sewankambo N. K., Kaplan J. E., Gray R. H. HIV risk factors in three geographic strata of rural Rakai District, Uganda. AIDS 1992; 6:983–989
     [Google Scholar]
  9. Bobat R., Coovadia H., Coutsoudis A., Moodley D. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J 1996; 15:604–610
     [Google Scholar]
  10. Thejpal R., Vaithilingum M., Coovadia H. M., Chetty R. Paediatric HIV infection. Lancet 1996; 348:1526–1527
     [Google Scholar]
  11. Ministry of Health, Ghana 1995 The AIDS Control Unit
  12. Adjorolo-Johnson G., De Cock K. M., Ekpini E. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462–466
     [Google Scholar]
  13. Mertens T. E., Belsey E., Stonebumer R. L. Global estimates and epidemiology of HIV-1 infections and AIDS: further heterogeneity in spread and impact. AIDS 1995; 9: Suppl A S259–S272
     [Google Scholar]
  14. Bagenda D., Mmiro F., Mirembe F., Nakabito C., Mugenyi D., Mukasa L. HIV-1 sero-prevalence rates in women attending prenatal clinics in Kampala, Uganda. IX International Conference on AIDS and STD Africa; Kampala: 1995 (Abstract Mo CO 16)
    [Google Scholar]
  15. Working Group on Mother-to-Child Transmission of HIV Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe from 13 perinatal studies J AIDS Hum Retroviral 1995; 8:506–510
     [Google Scholar]
  16. The European Collaborative Study Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994; 94:815–819
     [Google Scholar]
  17. Mayaux M.-J., Blanche S., Rouzioux C. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 years of follow-up observation. J AIDS Hum Retroviral 1995; 8:188–194
     [Google Scholar]
  18. Kind C., Brandle B., Wyler C.-A. Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur J Pediatr 1992; 151:441–448
     [Google Scholar]
  19. Thomas P. A., Weedon J., Krasinski K., Abrams E. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994; 13:489–495
     [Google Scholar]
  20. Lepage P., Van de Perre , Msellati P. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. Am J Epidemiol 1993; 137:589–599
     [Google Scholar]
  21. Marum L. H., Bagenda D., Guay L. Three-year mortality in a cohort of HIV-1 infected and uninfected Ugandan children. XI International Conference on AIDS; Vancouver: 1996 (Abstract WeB312)
    [Google Scholar]
  22. Biggar R. J., Miotti P. G., Taha T. E. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347:1647–1650
     [Google Scholar]
  23. Sherwen L. N. Human immunodeficiency virus infection during the perinatal period: a review of literature concerning pregnant women and neonates. J Perinatol 1995; 15:54–66
     [Google Scholar]
  24. Ryder R. W., Nsa W., Hassig S. E. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989; 320:1637–1642
     [Google Scholar]
  25. Javaisas E., Koch M. A., Schäfer A., Stauber M., Löwenthal D. LAV/HTLV-III in a 20-week fetus. Lancet 1985; 2:1129
     [Google Scholar]
  26. Brossard Y., Aubin J.-T., Mandebrot L. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995; 9:359–366
     [Google Scholar]
  27. Chouquet C., Burgard M., Richardson S., Rouzioux C., Costagliola D. Timing of mother-to-child HIV-transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS 1997; 11:1183–1184
     [Google Scholar]
  28. Duliege A.-M., Amos C. I., Felton S., Biggar R. J., Goedert J. J. Birth order, delivery route and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J Pediatr 1995; 126:625–632
     [Google Scholar]
  29. St Louis M. E., Kamenga M., Brown C. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993; 269:2853–2859
     [Google Scholar]
  30. Mostad S. B., Kreiss J. K. Shedding of HIV-1 in the genital tract. AIDS 1996; 10:1305–1315
     [Google Scholar]
  31. Sperling R. S., Shapiro D. E., Coombs R. W. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335:1621–1629
     [Google Scholar]
  32. Bredberg-Raden U., Urassa W., Urassa E. Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania. J AIDS Hum Retroviral 1995; 8:182–187
     [Google Scholar]
  33. Van de Perre P., Simonon A., Msellati P. Postnatal transmission of human immunodeficiency vims type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med 1991; 325:593–598
     [Google Scholar]
  34. Bulterys M., Chao A., Dushimimana A. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS 1993; 7:1639–1645
     [Google Scholar]
  35. Matheson P. B., Thomas P. A., Abrams E. J. Heterosexual behavior during pregnancy and perinatal transmission of HIV-1. AIDS 1996; 10:1249–1256
     [Google Scholar]
  36. European Collaborative Study Risk factors for mother-to-child transmission of HIV-1. Lancet 1992; 339:1007–1012
     [Google Scholar]
  37. Landesman S. H., Kalish L. A., Bums D. N. Obstetrical factors and the transmission of human immunodeficiency vims type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996; 334:1617–1623
     [Google Scholar]
  38. Dunn D. T., Newell M. L., Mayaux M. J. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies. J Acquir Immun Defic Syndr 1994; 7:1064–1066
     [Google Scholar]
  39. Dunn D. T., Newell M. L., Ades A. E., Peckham C. S. Risk of human immunodeficiency vims type 1 transmission through breast feeding. Lancet 1992; 340:585–588
     [Google Scholar]
  40. Kliks S. C., Wara D. W., Landers D. V., Levy J. A. Features of HIV-1 that could influence matemal-child transmission. JAMA 1994; 272:467–474
     [Google Scholar]
  41. Scarlatti G., Albert J., Rossi P. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993; 168:207–210
     [Google Scholar]
  42. Semba R. D., Graham N. M. H., Caiaffa W. T., Margolick J. B., Clement L., Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency vims type 1 infection. Arch Intern Med 1993; 153:2149–2154
     [Google Scholar]
  43. Semba R. D., Miotti P. G., Chiphangwi J. D. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Infect Dis 1995; 21:966–972
     [Google Scholar]
  44. Jackson J. B., Piwowar E., Horn D. Maternal HIV-1 RNA serum levels and vertical transmission in Uganda. IX International Conference on AIDS and STD; Kampala: 1995 (Abstract Tu A136)
    [Google Scholar]
  45. Mofenson L. M. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency vims. Pediatr Infect Dis J 1995; 14:169–177
     [Google Scholar]
  46. Marlink R. Lessons from the second AIDS virus, HIV-2. AIDS 1996; 10:689–699
     [Google Scholar]
  47. Semba R. D., Miotti P. G., Chiphangwi J. D. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343:1593–1597
     [Google Scholar]
  48. Coutsoudis A., Bobat R. A., Coovadia H. M., Kuhn L., Tsai W. Y., Stein Z. A. The effect of vitamin A Supplementation on the morbidity of children born to HIV-infected women. Am J Puhl Health 1995; 85:1076–1081
     [Google Scholar]
  49. Palasanthiran P., Ziegler J. B., Stewart G. J. Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 1993; 167:441–444
     [Google Scholar]
  50. Hira S. K., Mangrola U. G., Mwale C. Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr 1990; 117:421–424
     [Google Scholar]
  51. Gabiano C., Tovo P.-A., de Martino M. Mother-to-child transmission of human immunodeficiency virus type 1: risk of infection and correlates of transmission. Pediatrics 1992; 90:369–374
     [Google Scholar]
  52. Bulterys M., Chao A., Dushimimana A., Saah A. HIV-1 seroconversion after 20 months of age in a cohort of breastfed children born to HIV-1 infected women in Rwanda. AIDS 1995; 9:93–94
     [Google Scholar]
  53. Datta P., Embree J. E., Kreiss J. K. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi study. J Infect Dis 1994; 170:1134–1140
     [Google Scholar]
  54. Ndugwa C., Marum L., Tindyebwa D. Infrequent occurrence of late HIV-1 sero-conversion in Ugandan children. XI International Conference on AIDS and STD; Kampala: 1995 (Abstract TH C288)
    [Google Scholar]
  55. Ekpini E. R., Wiktor S. Z., Satten G. A. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, 1Cote d’ Ivoire. Lancet 1997; 349:1054–1059
     [Google Scholar]
  56. Karlsson K., Massawe A., Urassa E. Late postnatal transmission of human immunodeficiency virus type 1 infection from mothers to infants in Dar es Salaam, Tanzania. Pediatr Infect Dis J 1997; 16:963–967
     [Google Scholar]
  57. Ruff A. J., Coberly J., Halsey N. A. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immun Defic Syndr 1994; 7:68–73
     [Google Scholar]
  58. Van de Perre P., Simonon A., Hitimana D. G. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 1993; 341:914–918
     [Google Scholar]
  59. Guay L. A., Horn D. L., Mmiro F. Detection of human immunodeficiency virus type 1 (HIV-1) DNA and P24 antigen in breast milk of HIV-1 infected Ugandan women and vertical transmission. Pediatrics 1996; 98:438–444
     [Google Scholar]
  60. de Martino M., Tovo P.-A., Tozzi A. E. HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS 1992; 6:991–997
     [Google Scholar]
  61. Nagelkerke N. J. D., Moses S., Embree J. E., Jenniskens F., Plummer F. A. The duration of breast feeding by HIV-1 infected mothers in developing countries: balancing benefits and risks. J Acquir Immun Defic Syndr 1995; 8:176–181
     [Google Scholar]
  62. Nduati R. W., John G. C., Richardson B. A. Human immunodeficiency virus type 1-infected cells in breast milk; association with immunosuppression and vitamin A deficiency. J Infect Dis 1995; 172:1461–1468
     [Google Scholar]
  63. World Health Organization Consensus statement from the WHO/UNICEF consultation on HIV transmission and breast feeding. Wkly Epidemiol Rec 1992; 24:177–179
     [Google Scholar]
  64. Lepage P., Hitimana D.-G. Natural history and clinical presentation of HIV-1 infection in children. AIDS 1991; 5: Suppl 1S117–S125
     [Google Scholar]
  65. Chintu C., Luo C., Bhat G. Impact of the human immunodeficiency virus type-1 on common pediatric illnesses in Zambia. J Trop Pediatr 1995; 41:348–353
     [Google Scholar]
  66. Vetter K. M., Djomand G., Zadi F. Clinical spectrum of human immunodeficiency virus disease in children in a west African city. Project RETRO-C1. Pediatr Infect Dis J 1996; 15:438–442
     [Google Scholar]
  67. Graham S. M., Daley H. M., Ngwira B. Finger clubbing and HIV infection in Malawian children. Lancet 1997; 349:31
     [Google Scholar]
  68. Bannerman C., Chitsike I. Cor pulmonale in children with human immunodeficiency virus infection. Ann Trop Paediatr 1995; 15:129–134
     [Google Scholar]
  69. Lucas S. B., Peacock C. S., Hounnou A. Disease in children infected with HIV in Abidjan, Cote d’Ivoire. BMJ 1996; 312:335–338
     [Google Scholar]
  70. Jeena P. M., Coovadia H. M. Chrystal V Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr 1996; 16:361–368
     [Google Scholar]
  71. Ikeogu M. O., Wolf B., Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997; 76:124–128
     [Google Scholar]
  72. Lepage P., Van de Perre P., Van Vliet G. Clinical and endocrinologic manifestations in perinatally human immuno-deficiency virus type 1-infected children aged 5 years or older. Am J Dis Child 1991; 145:1248–1251
     [Google Scholar]
  73. Luo C., Chintu C., Bhat G. Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thiacetazone-free regimen. Tuber Lung Dis 1994; 75:110–115
     [Google Scholar]
  74. Mudido-Musoke P., Marum L., Bagenda D. Tuberculosis and HIV-1 infection in a cohort of Ugandan children. XI International Conference on AIDS; Vancouver: 1996 (Abstract We B306)
    [Google Scholar]
  75. Sassan-Morokro M., De Cock K. M., Ackah A. Tuberculosis and HIV infection in children in Abidjan, Cote d’Ivoire. Trans R Soc Trop Med Hyg 1994; 88:178–181
     [Google Scholar]
  76. Mukiibu J. M., Banda L., Liomba N. G., Sungani F. C. M., Parkin D. M. Spectrum of childhood cancers in Malawi 1985–1993. East Afr Med J 1995; 72:25–29
     [Google Scholar]
  77. Coulter J. B. S., Ndugwa C. M. HIV related Kaposi sarcoma. Arch Dis Child 1996; 75:547
     [Google Scholar]
  78. Subramanyam V. R., Mittimila E., Hart C. A., Broadhead R. L. Cryptococcal meningitis in African children. Ann Trop Paediatr 1997; 17:165–167
     [Google Scholar]
  79. Greenberg A. E., Nsa W., Ryder R. W. Plasmodium falciparum malaria and perinatally acquired human immuno-deficiency virus type 1 infection in Kinshasa, Zaire. A prospective longitudinal cohort study of 587 children. N Engl J Med 1991; 325:105–109
     [Google Scholar]
  80. Taha T. E. T., Canner J. K., Dallabetta G. A. Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi. Trans R Soc Trop Med Hyg 1994; 88:164–165
     [Google Scholar]
  81. Kalyesubula I., Mudido-Musoke P., Marum L. Effects of malaria infection in HIV-1 infected children in a Ugandan cohort. XI International Conference on AIDS; Vancouver: 1996 (Abstract We B314)
    [Google Scholar]
  82. Nelson E., Weikert M., Phillips J. A. Paediatric treatment costs and the HIV epidemic. Cent Afr J Med 1995; 41:139–144
     [Google Scholar]
  83. Lallemont M., Lallemont-le-Coeur S., Cheynier D. Mother-child transmission of HIV-1 and infant survival in Brazzaville, Congo. AIDS 1989; 3:643–646
     [Google Scholar]
  84. Taha T. E. T., Dallabetta G. A., Canner J. K. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int J Epidemiol 1995; 24:1022–1029
     [Google Scholar]
  85. Comeau A. M., Pitt J., Hillyer G. A. Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. J Pediatr 1996; 129:111–118
     [Google Scholar]
  86. Bredberg-Raden U., Urassa E., Grankvist O. Early diagnosis of HIV-1 infection in infants in Dar es Salaam, Tanzania. Clin Diagn Virol 1995; 4:163–173
     [Google Scholar]
  87. McIntosh K., Comeau A. M., Wara D. The utility of IgA antibody to human immunodeficiency virus type 1 in early diagnosis of vertically transmitted infection. National Institute of Allergy and Infectious Diseases and National Institute of Child Health and Human Development Women and Infants Transmission Study Group. Arch Pediatr Adolesc Med 1996; 150:598–602
     [Google Scholar]
  88. Moodley D., Coovadia H. M., Bobat R. A., Sullivan J. L. HIV-1 specific immunoglobulin A antibodies as an effective marker of perinatal infection in developing countries. J Trop Pediatr 1997; 43:80–83
     [Google Scholar]
  89. Lyamuya E., Bredberg-Raden U., Massawe A. A modified HIV-1 P24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother to infant transmission of HIV-1 in Dar es Salaam, Tanzania. IX International Conference on AIDS and STD; Kampala: 1995 (Abstract TuA 135)
    [Google Scholar]
  90. Weltman A. C., Rose D. N. The safety of Bacille Calmette-Guerin vaccination in HIV infection and AIDS. AIDS 1993; 7:149–157
     [Google Scholar]
  91. Edwards K. M., Kernodle D. S. Possible hazards of routine Bacillus Calmette-Guerin immunization in human immunodeficient virus-infected children. Pediatr Infect Dis J 1996; 15:836–838
     [Google Scholar]
  92. Borkowsky W., Rigaud M., Krasinski K., Moore T., Lawrence R., Pollack H. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr 1992; 120:371–375
     [Google Scholar]
  93. Gibb D., Spoulou V., Giacomelli A. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1995; 14:129–135
     [Google Scholar]
  94. King J. C., Vink P. E., Farley J. J. Comparisons of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus infected children. Pediatr Infect Dis J 1996; 15:192–196
     [Google Scholar]
  95. Rutstein R. M., Rudy B. J., Cnaan A. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine. Arch Pediatr Adolesc Med 1996; 150:838–841
     [Google Scholar]
  96. Preble E. A. Impact of HIV/AIDS on African children. Soc Sci Med 1990; 31:671–680
     [Google Scholar]
  97. Taha T. E., Biggar R. J., Broadhead R. L. Effect of cleansing the birth canal with antiseptic solution of maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997; 315:216–219
     [Google Scholar]
  98. Dolin R. Human studies in the development of human immunodeficiency virus vaccines. J Infect Dis 1995; 172:1175–1183
     [Google Scholar]
  99. Mansergh G., Haddix A. C., Steketee R. W. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 1996; 276:139–145
     [Google Scholar]
  100. Office of National Statistics Travel trends. London: Office of National Statistics; 1995
     [Google Scholar]
  101. Steffen R. Health risk for short-term travelers. In Steffen R., Lobel H. O., Haworth J., Bradley D. J. (eds) Travel medicine New York: Springer; 198928–36
     [Google Scholar]
  102. Department of Health Health information for overseas travel. London: HMSO; 1995
     [Google Scholar]
  103. Brabin B. J., Ganley Y. Imported malaria in children in the UK. Arch Dis Child 1997; 77:76–81
     [Google Scholar]
  104. Churchill D. R., Chiodini P. L., McAdam K. P. W. J. Screening the returned traveller. Br Med Bull 1993; 49:465–474
     [Google Scholar]
  105. Felton J. M., Bryceson A. D. M. Fever in the returning traveller. Br J Hosp Med 1996; 55:705–711
     [Google Scholar]
  106. Humar A., Keystone J. Evaluating fever in travellers returning from tropical countries. BMJ 1996; 312:953–956
     [Google Scholar]
  107. Stanfield J. P., Reid D. Imported infections in children. JR Coll Physicians Lond 1980; 14:232–237
     [Google Scholar]
  108. Riordan F. A. I., Tarlow M. J. Imported infections in East Birmingham children. Postgrad Med J 1998; 74:36–37
     [Google Scholar]
  109. Varaine F., Caugant D. A., Riou J. Y. Meningitis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg 1997; 91:3–7
     [Google Scholar]
  110. Killalea D., Ward L. R., Roberts D. International epidemiological and microbiological study of outbreak of Salmonella agona infection from a ready to eat savoury snack. 1. England and Wales and the United States. BMJ 1996; 313:1105–1107
     [Google Scholar]
  111. Anonymous Salmonella anatum infection in infants linked to dried milk. Commun Dis Rep CDR Wkly 1997; 7:33–36
     [Google Scholar]
  112. Gay N., Ramsay M., Cohen B. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep CDR Rev 1997; 7:R17–R21
     [Google Scholar]
  113. Wilson M. E., Levins R., Spielman A. (eds) Disease in evolution: global changes and emergence of infectious diseases New York: New York Academy of Sciences; 1994 (Annals of the New York Academy of Sciences, Vol 740)
    [Google Scholar]
  114. Wilson M. E. Travel and the emergence of infectious diseases. Emerg Infect Dis 1995; 1:39–46
     [Google Scholar]
  115. HIV and STD Division, Communicable Disease Surveillance Centre Health and population occasional paper. Sexual health and health care: HIV, AIDS and sexually transmitted infections, global epidemiology, impact and prevention. London: Overseas Development Administration; 1996
     [Google Scholar]
  116. Ades A. E., Parker S., Cubitt D. Two methods for assessing the risk-factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988–91. AIDS 1992; 6:1031–1036
     [Google Scholar]
  117. Gubler D. J., Clark G. G. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1:55–57
     [Google Scholar]
  118. Galazka A. M., Robertson S. E., Oblapinko G. P. Resurgence of diphtheria. Eur J Epidemiol 1995; 11:95–105
     [Google Scholar]
  119. Davies P. D. O. Adult tuberculosis. In Hart C. A., Beeching N. J., Duerden B. I. (eds) Tuberculosis into the next century J Med Microbiol 1996; 44:11–14
     [Google Scholar]
  120. Medical Research Council Cardiothoracic Epidemiology Group Tuberculosis in children: a national survey of notifications in England and Wales in 1988. Arch Dis Child 1994; 70:497–500
     [Google Scholar]
  121. Raviglione M., Snider D. E., Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 275:220–226
     [Google Scholar]
  122. Anonymous A case of human rabies acquired in Nigeria. Commun Dis Rep CDR Wkly 1996; 6:363
     [Google Scholar]
  123. Barnett E. D., Chen R. Children and international travel: immunizations. Pediatr Infect Dis J 1995; 14:982–992
     [Google Scholar]
  124. McKee M. Travel associated illness. We need to stop blaming the victim. BMJ 1996; 312:925–926
     [Google Scholar]
  125. Giesecke J. Surveillance of infectious diseases in the European Union. Lancet 1996; 348:1534
     [Google Scholar]
  126. Hall S. Current epidemiology of childhood infections. Br Med Bull 1986; 42:127–130
     [Google Scholar]
  127. Stuart J. M., Monk P. N., Lewis D. A., Constantine C., Kaczmarski E. B., Cartwright K. A. V. Investigation of clusters of meningococcal disease. PHLS Meningococcus Working Group and Public Health Medicine Environmental Group. Commun Dis Rep CDR Rev 1997; 7:R3–R5
     [Google Scholar]
  128. Kaczmarski E. B., Cartwright K. A. V. Control of meningococcal disease: guidance for microbiologists. CCDC Consultant in Communicable Disease Control, England. Commun Dis Rep CDR Rev 1995; 5:R196–R198
     [Google Scholar]
  129. McCormick A. The notification of infectious diseases in England and Wales. Commun Dis Rep CDR Rev 1993; 3:R19–R25
     [Google Scholar]
  130. Henry R. Co-Surv: a regional computing strategy for communicable disease surveillance. PHLS Microbiol Digest 1996; 13:26–28
     [Google Scholar]
  131. Department of Health: Report of the Committee of Inquiry into the future development of the Public Health Function London: HMSO; 1988Cm 289
  132. Department of Health (Hospital Infection Working Group) Hospital Infection Control. London: HMSO; 1995
     [Google Scholar]
  133. Editorial Eur Surveillance 1996; 1:1
     [Google Scholar]
  134. PHLS Notifications of infectious diseases – Table 1. Commun Dis Rep 1997; 7:25
     [Google Scholar]
  135. Riordan F. A. I., Thomson A. P. J., Sills J. A., Hart C. A. Who spots the spots? The diagnosis and treatment of early meningococcal disease in children. BMJ 1996; 313:1255–1256
     [Google Scholar]
  136. Riordan F. A. I., Thomson A. P. J. Early presentation of meningococcal disease after media publicity. Arch Dis Child 1993; 69:711
     [Google Scholar]
  137. Thomson A. P. J., Hayhurst G. Press publicity in meningococcal disease. Arch Dis Child 1993; 69:166–169
     [Google Scholar]
  138. Pollard A. J., Booy R., Nadel S., Levin M. Secondary cases of meningococcal disease. Arch Dis Child 1996; 75:546–547
     [Google Scholar]
  139. Stuart J. M., Monk P. N., Lewis D. A., Constantine C., Kaczmarski E. B., Cartwright K. A. Management of clusters of meningococcal disease. PHLS Meningococcus Working Group and Public Health Medicine Environmental Group. Commun Dis Rep CDR Rev 1997; 7:R3–R5
     [Google Scholar]
  140. Welsby P. D., Golledge C. L. Meningococcal meningitis. BMJ 1990; 300:1150–1153
     [Google Scholar]
  141. CMO letter Meningococcal infection: meningitis and septicaemia. PL CMO (97) 1
  142. Strang J. R., Pugh E. J. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. BMJ 1992; 305:141–143
     [Google Scholar]
  143. Cartwright K., Reilly S., White D., Stuart J. Early treatment with parenteral penicillin in meningococcal disease. BMJ 1992; 305:143–147
     [Google Scholar]
  144. Gossain S., Constantine C. E., Webberley J. M. Early parenteral penicillin in meningococcal disease. BMJ 1992; 305:523–524
     [Google Scholar]
  145. Cartwright K., Strang J., Gossain S., Begg N. Early treatment in meningococcal disease. BMJ 1992; 305:774
     [Google Scholar]
  146. Sorensen H. T., Moller-Petersen J., Krarup H. B., Pedersen H., Hansen H., Hamburger H. Early treatment of meningococcal disease. BMJ 1992; 305:774
     [Google Scholar]
  147. Woodward C. M., Jessop E. G., Wale M. C. J. Early management of meningococcal disease. Commun Dis Rep CDR Rev 1995; 5:R135–R137
     [Google Scholar]
  148. Riordan F. A. I. Factors associated with mortality from meningococcal disease in Merseyside children. PhD thesis University of Liverpool; 1995
     [Google Scholar]
  149. Thomson A. P. J. Section 70: Meningococcal disease. In Davies E. G., Elliman D. A. C., Hart C. A., Nicoll A., Rudd P. T. (eds) Manual of childhood infections London: WB Saunders; 1996257–265
     [Google Scholar]
  150. Thompson A. P. J., Sills J. A., Hart C. A. Validation of the Glasgow meningococcal septicaemia prognostic score: a 10-year retrospective survey. Crit Care Med 1991; 19:26–30
     [Google Scholar]
  151. Marzouk O. Clinical and laboratory aspects of meningococcal disease in children. MD thesis University of Liverpool; 1994
     [Google Scholar]
  152. Background Product Information: rBPI in meningococcal disease XOMA Corporation; 1996
  153. Heyderman R. S., Klein N., Levin M. Patho-physiology and management of meningococcal septicaemia. In David T. (ed) Recent advances in paediatrics Edinburgh: Churchill Living-stone; 19921–18
     [Google Scholar]
  154. Derkx B. Anderson the Centoxin Study Group A randomised placebo-controlled sequential trial to study the efficacy of HA-1A human monoclonal antibody in children with meningococcal septic shock (abstract). Proceedings of the European Society for Paediatric Intensive Care; Autumn: 1996
     [Google Scholar]
  155. Westendorp R. G. J., Langermans J. A. M., Huizinga T. W. J. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:170–173
     [Google Scholar]
  156. Murray C. J. L., Lopez A. D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269–1276
     [Google Scholar]
  157. Murray C. J. L., Lopez A. D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1498–1504
     [Google Scholar]
  158. Bern C., Martines J., de Zoysa I., Glass R. I. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ 1992; 70:705–714
     [Google Scholar]
  159. Cunliffe N. A., Bresee J. S., Gondwe J., Hart C. A. The epidemiology of diarrhoeal disease in children at Queen Elizabeth Central Hospital, Blantyre, Malawi 1994–1997. Malawi Med J 1998 (in press)
    [Google Scholar]
  160. Hart C. A., Cunliffe N. A. Diagnosis and causes of viral gastroenteritis. Curr Opin Infect Dis 1996; 9:333–336
     [Google Scholar]
  161. Cascio A., Bozco M., Vizzi E., Giammanco A., Ferraro D., Arista S. Identification of picobirnaviruses from faeces of Italian children suffering from acute diarrhea. Eur J Epidemiol 1996; 12:545–547
     [Google Scholar]
  162. Estes M. K. Advances in molecular biology: impact on rotavirus vaccine development. J Infect Dis 1996; 174: Suppl 1S37–S46
     [Google Scholar]
  163. Hart C. A., Cunliffe N. A. Viral gastroenteritis. Curr Opin Infect Dis 1997; 10:408–413
     [Google Scholar]
  164. Gentsch J. R., Woods P. A., Ramachandran M. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis 1996; 174: Suppl 1S30–S36
     [Google Scholar]
  165. Cunliffe N. A., Das B. K., Ramachandran M. Sequence analysis demonstrates that VP6, NSP1 and NSP4 genes of Indian neonatal rotavirus strain 116E are of human origin. Virus Genes 1997; 15:39–44
     [Google Scholar]
  166. Aponte C., Poncet D., Cohen J. Recovery and characterization of a replicase complex in rotavirus-infected cells using a monoclonal antibody against NSP2. J Virol 1996; 70:985–991
     [Google Scholar]
  167. Tian P., Ball J. M., Zeng C. Q. U., Estes M. K. The rotavirus nonstructural glycoprotein NSP4 possesses membrane destabilization activity. J Virol 1996; 70:6973–6981
     [Google Scholar]
  168. Ball J. M., Tian P., Zeng C. Q.-Y., Morris A. P., Estes M. K. Age-dependent diarrhea induced by a rotavirus nonstructural glycoprotein. Science 1966; 272:101–104
     [Google Scholar]
  169. Cunliffe N. A., Woods P. A., Leite J. P. G. Sequence analysis of NSP4 gene of human rotavirus allows classification into two main genetic groups. J Med Virol 1997; 53:41–50
     [Google Scholar]
  170. Cook S. M., Glass R. I., LeBaron C. W., Ho M.-S. Global seasonality of rotavirus infections. Bull World Health Organ 1990; 68:171–177
     [Google Scholar]
  171. Glass R. I., Kilgore P. E., Holman R. C. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis 1996; 174: Suppl 1S5–S11
     [Google Scholar]
  172. Ryan M. J., Ramsay M., Brown D., Gray N. J., Farrington C. P., Wall P. G. Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis 1996; 174: Suppl 1S12–S18
     [Google Scholar]
  173. Paje-Villar E., Co B. G., Caradang E. H. Non-bacterial diarrhoea in children in the Philippines. Ann Trop Med Parasitol 1994; 88:53–58
     [Google Scholar]
  174. Tabassum S., Shears P., Hart C. A. Genomic characterization of rotavirus strains obtained from hospitalized children with diarrhoea in Bangladesh. J Med Virol 1994; 43:50–56
     [Google Scholar]
  175. Cunliffe N. A., Kilgore P. E., Bresee J. S., Luo N., Hart C. A., Glass R. I. Epidemiology of rotavirus diarrhoea in Africa: a review of studies to anticipate rotavirus immunization. Bull World Health Organ 1998 (in press)
    [Google Scholar]
  176. Blacklow N. R., Greenberg H. B. Viral gastroenteritis. N Engl J Med 1991; 325:252–264
     [Google Scholar]
  177. Batt R. M., Embaye H., van de Waal S., Burgess D., Edwards G. B., Hart C. A. Application of organ culture of small intestine to the investigation of enterocyte damage by equine rotavirus. J Pediatr Gastroenterol Nutr 1995; 20:326–332
     [Google Scholar]
  178. Raza S., Graham S. M., Allen S. J., Sultana S., Cuevas L., Hart C. A. Lactobacillus GG promotes recovery from acute non-bloody diarrhea in Pakistan. Pediatr Infect Dis J 1995; 14:107–111
     [Google Scholar]
  179. Pant A. R., Graham S. M., Allen S. J. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 1996; 42:162–165
     [Google Scholar]
  180. Guarino A., Canani R. B., Russo S. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 1994; 93:12–16
     [Google Scholar]
  181. Keusch G. T., Cash R. A. A vaccine against rotavirus – when is too much too much?. N Engl J Med 1997; 337:1228–1229
     [Google Scholar]
  182. Smith J. C., Haddix A., Teutsch S. M., Glass R. I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Pediatrics 1995; 96:609–615
     [Google Scholar]
  183. Velazquez F. R., Matson D. O., Calva J. J. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022–1028
     [Google Scholar]
  184. Bernstein D. I., Glass R. I., Rodgers G., Davidson B. L., Sack D. A. for the US Rotavirus Vaccine Efficacy Group. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA 1995; 273:1191–1196
     [Google Scholar]
  185. Linhares A. C., Gabbay Y. B., Mascarenhas J. D. P. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ 1996; 74:491–500
     [Google Scholar]
  186. Perez-Schael I., Guntinas M. J., Perez M. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuala. N Engl J Med 1997; 337:1181–1187
     [Google Scholar]
  187. Joensuu J., Koskenniemi E., Pang X.-L., Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350:1205–1209
     [Google Scholar]
  188. Noel J. S., Lee T. W., Kurtz J. B., Glass R. I., Monroe S. S. Typing of human astroviruses from clinical isolates by enzyme immuno-assay and nucleotide sequencing. J Clin Microbiol 1995; 33:797–801
     [Google Scholar]
  189. Lee T. W., Kurtz J. B. Prevalence of human astrovirus serotypes in the Oxford region 1976–92, with evidence for two new serotypes. Epidemiol Infect 1994; 112:187–193
     [Google Scholar]
  190. Koopmans M. P. G., Bijen M. H. C., Monroe S. S., Vinje J. Astro-virus-type specific antibody prevalence in Utrecht, the Netherlands. American Society for Virology, 16. Annual meeting Bozemen, Montana Abstract W35/1 1997158
     [Google Scholar]
  191. Belliot G., Laveran H., Monroe S. S. Outbreak of gastroenteritis in military recruits associated with serotype 3 astrovirus infection. J Med Virol 1997; 51:101–106
     [Google Scholar]
  192. Palombo E. A., Bishop R. F. Annual incidence, serotype distribution, and genetic diversity of human astrovirus isolates from hospitalized children in Melbourne, Australia. J Clin Microbiol 1996; 34:1750–1753
     [Google Scholar]
  193. Mitchell D. K., Monroe S. S., Jiang X., Matson D. O., Glass R. I., Pickering L. K. Virologic features of an astrovirus diarrhea outbreak in a daycare center revealed by reverse transcriptase-polymerase chain reaction. J Infect Dis 1995; 172:1437–1444
     [Google Scholar]
  194. Unicomb L. E., Jarecki-Khan K., Hall A., Podder G. Previous enteric adenovirus does not protect against subsequent symptomatic infection: longitudinal follow-up of eight infants. Microbiol Immunol 1996; 40:161–168
     [Google Scholar]
  195. Clarke I. N., Lambden P. R. The molecular biology of caliciviruses. J Gen Virol 1997; 78:291–301
     [Google Scholar]
  196. Graham D. Y., Jiang X., Tanaka T., Opekun A. R., Madore H. P., Estes M. K. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis 1994; 170:34–43
     [Google Scholar]
  197. Dowell S. F., Groves C., Kirkland K. B. A multistate outbreak of oyster-associated gastroenteritis: implications for interstate tracing of contaminated shellfish. J Infect Dis 1995; 171:1497–1503
     [Google Scholar]
  198. Levett P. N., Gu M., Luan B. Longitudinal study of molecular epidemiology of small round-structured viruses in a pediatric population. J Clin Microbiol 1996; 34:1497–1501
     [Google Scholar]
  199. Cubitt W. D., Jiang X. Study on occurrence of human calicivirus (Mexico strain) as cause of sporadic cases and outbreaks of calicivirus-associated diarrhoea in the United Kingdom, 1983–1995. J Med Virol 1996; 48:273–277
     [Google Scholar]
  200. Smith A. W., Skilling D. E., Cherry N., Mead J. H., Matson D. O. Calicivirus emergence from ocean reservoirs: zoonotic and interspecies movements. Emerg Infect Dis 1998; 4:13–20
     [Google Scholar]
  201. Pereira H. E., Flewett T. W., Candeias J. A. N., Barth O. M. A virus with a bisegmented double-stranded RNA genome in rat (Oryzomys nigripes) intestines. J Gen Virol 1988; 69:2749–2754
     [Google Scholar]
  202. Ludert J. E., Liprandi F. Identification of viruses with bi- and tri-segmented double stranded RNA genomes in faeces of children with gastroenteritis. Res Virol 1993; 144:219–224
     [Google Scholar]
  203. Elbom J. S., Shale D. J., Britton J. R. Cystic fibrosis: current survival and population estimates for the year 2000. Thorax 1991; 46:881–885
     [Google Scholar]
  204. Smith J. J., Travis S. M., Greenberg E. P., Welsh M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85:229–236
     [Google Scholar]
  205. Armstrong D. S., Grimwood K., Carzino R., Carlin J. B., Olinsky A., Phelan P. D. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995; 310:1571–1572
     [Google Scholar]
  206. Stutman H. To Keflex or not to Keflex: long-term antibiotics in CF. Presented at the Ninth North American Cystic Fibrosis Conference, October 1995
     [Google Scholar]
  207. Huang N. N., Schidlow D. V., Szatrowski T. H. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med 1987; 82:871–879
     [Google Scholar]
  208. Valerius N. H., Koch C., Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338:725–726
     [Google Scholar]
  209. Mukhopadhyay S., Singh M., Cater J. I., Ogston S., Franklin M., Olver R. E. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta–analysis of benefits and risks. Thorax 1996; 51:364–368
     [Google Scholar]
  210. Govan J. R. W., Brown P. H., Maddison J. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342:15–19
     [Google Scholar]
  211. Cheng K., Smyth R. L., Govan J. R. W. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348:639–642
     [Google Scholar]
  212. Gilligan P., Jordan M., Wait K., Riddell S., Rogers E. Oxacillin resistant Staphylococcus aureus in patients with cystic fibrosis (CF). Ped Pulmonol 1996 Suppl 13297 (Abstract)
    [Google Scholar]
  213. Denton M., Kerr K. G., Littlewood J. M. Molecular epidemiology of Stenotrophomonas maltophila in home and hospital environment of children with cystic fibrosis. Ped Pulmonol 1996 Suppl 13297 (Abstract)
    [Google Scholar]
  214. Walters S., Smith E. G. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet 1993; 342:3–4
     [Google Scholar]
  215. Wang E. E. L., Prober C. G., Manson B., Corey M., Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984; 311:1653–1658
     [Google Scholar]
  216. Ramsey B. W., Gore E. J., Smith A. L., Cooney M. K., Redding C. J., Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 1989; 143:662–668
     [Google Scholar]
  217. Smyth A. R., Smyth R. L., Tong C. Y. W., Hart C. A., Heaf D. P. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995; 73:117–120
     [Google Scholar]
  218. Leonard E. M., van Saene H. K. F., Stoutenbeek C. P., Walker J., Tam P. K. H. An intrinsic pathogenicity index for microorganisms causing infection in a neonatal surgical unit. Microb Ecol Health Dis 1990; 3:151–158
     [Google Scholar]
  219. Singh-Naz N., Sprague B. M., Patel K. M., Pollack M. M. Risk factors for nosocomial infection in critically ill children: a prospective cohort study. Crit Care Med 1996; 24:875–878
     [Google Scholar]
  220. Mandelli M., Mosconi P., Langer M., Cigada M. Is pneumonia developing in patients in intensive care always a typical ‘nosocomial’ infection?. Lancet 1986; ii:1094–1095
     [Google Scholar]
  221. Brawley R. L., Weber D. J., Samsa G. P., Rutala W. A. Multiple nosocomial infections. An incidence study. Am J Epidemiol 1989; 130:769–780
     [Google Scholar]
  222. Garner J. S., Jarvis W. R., Emori T. G., Horan T. C., Hughes J. M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128–140
     [Google Scholar]
  223. Chevret S., Hemmer M., Carlet J., Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19:256–264
     [Google Scholar]
  224. Potgieter P. D., Hammond J. M. J. Etiology and diagnosis of pneumonia requiring ICU admission. Chest 1992; 101:199–203
     [Google Scholar]
  225. Rolando N., Gimson A., Wade J., Philpott Howard J., Casewell M., Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen on fulminant liver failure. Hepatology 1993; 17:196–201
     [Google Scholar]
  226. Korinek A. M., Laisne M. J., Nicolas M. H., Raskine L., Deroin V., Sanson Lepors M. J. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 1993; 21:1466–1473
     [Google Scholar]
  227. Leonard E. M., van Saene H. K. F., Shears P., Walker J., Tam P. K. Pathogenesis of colonization and infection in a neonatal surgical unit. Crit Care Med 1990; 18:264–269
     [Google Scholar]
  228. Van Saene H. K. F., Damjanovic V., Murray A. E., de la Cal M. A. How to classify infections in intensive care units – The carrier state, a criterion whose time has come?. J Hosp Infect 1996; 33:1–12
     [Google Scholar]
  229. A guide to sensitivity testing Report of the working party on antibiotic sensitivity testing of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 1991; 27: Suppl D 1–50
     [Google Scholar]
  230. Das I., Philpott C., George R. H. Central venous catheter-related septicaemia in paediatric cancer patients. J Hosp Infect 1997; 36:67–76
     [Google Scholar]
  231. Toltzis P., Yamashita T., Vilt L., Blumer J. L. Colonization with antibiotic-resistant gram-negative organisms in a paediatric intensive care unit. Crit Care Med 1997; 25:538–544
     [Google Scholar]
  232. Morar P., Singh V., Jones A. S., Hughes J., van Saene R. The impact of a tracheotomy on colonization and infection of lower airways in children requiring long-term ventilation. A prospective observational cohort study. Chest 1998; 113:77–85
     [Google Scholar]
  233. Spencer R. C. Definitions of nosocomial infections. In Emmerson A. M., Ayliffe G. A. J. (eds) Surveillance of nosocomial infections. Bailliere’s clinical infectious diseases London: Bailliere Tindall; 1996; 3237–252
     [Google Scholar]
  234. Jarvis W. R. Handwashing – the Semmelweis lesson forgotten?. Lancet 1994; 344:1311–1312
     [Google Scholar]
  235. Guidelines for prevention of nosocomial pneumonia Centers for Disease Control and Prevention. MMWR Morbid Mortal Wkly Rep 1997; 46: (RR–1) 1–79
     [Google Scholar]
  236. Stoutenbeek C. P., van Saene H. K. F., Miranda D. R., Zandstra D. F., Langrehr D. The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. J Trauma 1987; 27:357–364
     [Google Scholar]
  237. Sirvent J. M., Torres A., El-Ebiary M., Castro P., de Batlle J., Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 1997; 155:1729–1734
     [Google Scholar]
  238. Baxby D., van Saene H. K. F., Stoutenbeek C. P., Zandstra D. F. Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Intensive Care Med 1996; 22:699–706
     [Google Scholar]
  239. Liberati A., D’Amico R., Pifferi S. Antibiotic prophylaxis in adult patients treated in Intensive Care Units. In Douglas R., Bridges-Webb C., Glasziou P., Lozano J., Steinhoff M., Wang E. (eds) Acute respiratory infections module of the Cochrane database of systemic reviews (updated 3 June 1997). Available in the Cochrane Library (database on disk and CDROM). The Cochrane Collaboration; Issue 3 Oxford: Updated Software; 1997 Updated quarterly
    [Google Scholar]
  240. Silverman W. A., Anderson H. D., Blanc W. A., Crozier D. N. A difference in mortality rate and incidence of kemicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956; 18:614–624
     [Google Scholar]
  241. Dunn P. M. The possible relationship between the maternal administration of sulphamethoxypyridazine and hyperbilirubinaemia in the newborn. J Obstet Gynaec Brit Comm 1964; 71:128–131
     [Google Scholar]
  242. Sutherland J. M. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AM A J Dis Child 1959; 97:761–767
     [Google Scholar]
  243. Weiss C. F., Glazko A. J., Weston J. K. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med 1960; 262:787–794
     [Google Scholar]
  244. Hiller A., Olkkola K. T., Isohanni P., Saamivaara L. Unconsciousness associated with midazolam and erythromycin. Br J Anaesth 1990; 65:826–828
     [Google Scholar]
  245. Hughes J., Gill A., Leach H. J. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr 1994; 83:1194–1199
     [Google Scholar]
  246. Olkkola K. T., Aranko K., Luurila H. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993; 53:298–305
     [Google Scholar]
  247. van den Anker J. N. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996; 85:1393–1399
     [Google Scholar]
  248. Aperia A., Broberger O., Elinder G., Herin P., Zetterstrom R. Postnatal development of renal function in pre-term and full-term infants. Acta Paediatr Scand 1981; 70:183–187
     [Google Scholar]
  249. Van der Heijden A. J., Grose W. F., Ambagtsheer J. J., Provoost A. P., Wolff E. D., Sauer P. J. Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Pediatr 1988; 148:24–28
     [Google Scholar]
  250. Hughes J., Gill A. M., Mulheam H., Powell E., Choonara I. Steady state plasma concentrations of midazolam in critically ill infants and children. Ann Pharmacother 1996; 30:27–30
     [Google Scholar]
  251. Pons G., Carrier O., Richard M.-O. Developmental changes of caffeine elimination in infancy. Dev Pharmacol Ther 1988; 11:258–264
     [Google Scholar]
  252. Carrier O., Pons G., Rey E. Maturation of caffeine metabolic pathways in infancy. Clin Pharmacol Ther 1988; 44:145–151
     [Google Scholar]
  253. Choonara I., Gill A., Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996; 42:407–410
     [Google Scholar]
  254. Backman J. T., Olkkola K. T., Neuvonen P. J. Rifampin drastically reduces plasma concentrations and effects of oral midazolam. Clin Pharmacol Ther 1996; 59:7–13
     [Google Scholar]
  255. Thomson A. H., Thomson G. D., Hepburn M., Whiting B. A clinically significant interaction between ciprofloxacin and theophylline. Eur J Clin Pharmacol 1987; 33:435–436
     [Google Scholar]
  256. Parker A. C., Preston T., Heaf D., Kitteringham N. R., Choonara I. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test. Br J Clin Pharmacol 1994; 38:573–576
     [Google Scholar]
  257. Parker A. C., Pritchard P., Preston T., Dalzell A. M., Choonara I. Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test. Br J Clin Pharmacol 1997; 43:467–470
     [Google Scholar]
  258. Kearns G. L., Mallory G. B., Crom W. R., Evans W. E. Enhanced hepatic drug clearance in patients with cystic fibrosis. J Pediatr 1990; 117:972–979
     [Google Scholar]
  259. Jusko W. J., Mosovich L. L., Gerbracht L. M., Mattar M. E., Yaffe S. J. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 1975; 56:1038–1044
     [Google Scholar]
  260. Mehta S. Drug disposition in children with protein energy malnutrition. J Pediatr Gastroenterol Nutr 1983; 2:407–417
     [Google Scholar]
  261. Lares-Asseff I., Cravioto J., Santiago P., Perez-Ortiz B. Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children. Clin Pharmacol Ther 1992; 51:42–50
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-47-11-943
Loading
Infections in children
J. Med. Microbiol. 47, 943 (1998); https://doi.org/10.1099/00222615-47-11-943
/content/journal/jmm/10.1099/00222615-47-11-943
/content/journal/jmm/10.1099/00222615-47-11-943
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error